Please enable JavaScript to continue using this application.

Compare $ARTV vs $CYPH | Chartloom

Compare

$ARTV vs $CYPH

Artiva Biotherapeutics Inc · Cypherpunk Technologies Inc

ARTV

Artiva Biotherapeutics Inc

CYPH

Cypherpunk Technologies Inc

Compare $ARTV vs $CYPH

Comparing Artiva Biotherapeutics Inc and Cypherpunk Technologies Inc

ARTVArtiva Biotherapeutics Inc

CYPHCypherpunk Technologies Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

CYPHCypherpunk Technologies Inc

Market cap

$313M

P/E (TTM)

—

Forward P/E (NTM)

26.20x

Forward P/S (NTM)

6.06x

Rev growth (TTM)

—

YTD performance

160.2%

52W performance

292.0%

FCF yield

-11.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

CYPH

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

ARTV$337M

CYPH$313M

Enterprise Value

ARTV$36M

CYPH$305M

Price

ARTV$6.94

CYPH$2.94

P/E Ratio

ARTVN/A

CYPHN/A

P/S Ratio

ARTV0.00x

CYPH217.68x

EV/Sales

ARTV0.00x

CYPH0.00x

EV/EBITDA

ARTV0.00x

CYPH0.00x

P/B Ratio

ARTV0.96x

CYPH2.34x

P/FCF Ratio

ARTVN/A

CYPHN/A

EV/FCF

ARTV-0.46x

CYPH-8.83x

PEG Ratio

ARTVN/A

CYPHN/A

Forward P/E (NTM)

ARTVN/A

CYPH26.20x

Forward P/S (NTM)

ARTVN/A

CYPH6.06x

Revenue (TTM)

ARTV$0

CYPH$0

Revenue Growth (YoY)

ARTVN/A

CYPHN/A

Forward Rev Growth

ARTV404.4%

CYPH155.2%

Gross Margin (TTM)

ARTV0.0%

CYPH0.0%

Operating Margin (TTM)

ARTV0.0%

CYPH0.0%

EBITDA Margin (TTM)

ARTV0.0%

CYPH0.0%

Net Margin (TTM)

ARTV0.0%

CYPH0.0%

FCF Margin (TTM)

ARTVN/A

CYPHN/A

Net Income (TTM)

ARTV$-42M

CYPH$-877K

FCF (TTM)

ARTV$-77M

CYPH$-35M

EPS (TTM)

ARTV$0.00

CYPH-$0.00

ROE (TTM)

ARTV-6022.0%

CYPH-92.0%

ROA (TTM)

ARTV-5238.0%

CYPH-87.0%

ROIC (TTM)

ARTV-6019.0%

CYPH-92.0%

Cash

ARTV$301M

CYPH$8M

Debt

ARTV$0

CYPH$0

Net Cash/Debt

ARTV$301M

CYPH$8M

Current Ratio (TTM)

ARTV24.16x

CYPH79.19x

Quick Ratio (TTM)

ARTV23.97x

CYPH78.88x

Debt/Equity (TTM)

ARTV0.00x

CYPH0.00x

Debt/Assets (TTM)

ARTV0.0%

CYPH0.0%

Interest Coverage (TTM)

ARTVN/A

CYPHN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

CYPH0.00x

Beta

ARTV5.80

CYPH1.13

52W Performance

ARTV131.3%

CYPH292.0%

YTD Performance

ARTV64.1%

CYPH160.2%

% from 52W High

ARTV-52.2%

CYPH-29.8%

% from 52W Low

ARTV156.1%

CYPH648.1%

Asset Turnover (TTM)

ARTV0.00x

CYPH0.02x

FCF Yield (TTM)

ARTV-22.8%

CYPH-11.1%

Earnings Yield (TTM)

ARTV-12.5%

CYPH-0.3%

Dividend Yield (TTM)

ARTVN/A

CYPHN/A

Rule of 40

ARTV0.0

CYPH0.0

EV/GP/RG

ARTVN/A

CYPHN/A

Ticker research

View ARTV research View CYPH research

Metric	ARTV Artiva Biotherapeutics Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$337M	$313M
Enterprise Value	$36M	$305M
Price	$6.94	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	217.68x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	N/A	6.06x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	155.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-42M	$-877K
FCF (TTM)	$-77M	$-35M
EPS (TTM)	$0.00	-$0.00
ROE (TTM)	-6022.0%	-92.0%
ROA (TTM)	-5238.0%	-87.0%
ROIC (TTM)	-6019.0%	-92.0%
Financial Health
Cash	$301M	$8M
Debt	$0	$0
Net Cash/Debt	$301M	$8M
Current Ratio (TTM)	24.16x	79.19x
Quick Ratio (TTM)	23.97x	78.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.13
52W Performance	131.3%	292.0%
YTD Performance	64.1%	160.2%
% from 52W High	-52.2%	-29.8%
% from 52W Low	156.1%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-22.8%	-11.1%
Earnings Yield (TTM)	-12.5%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View CYPH research

Valuation

P/S Ratio

ARTV

0.00x

CYPH

217.68x

EV/FCF

CYPH

-8.83x

ARTV

-0.46x

Growth & revenue

Forward Revenue Growth

ARTV

404.4%

CYPH

155.2%

Profitability & performance

Gross Margin

ARTV

0.0%

CYPH

0.0%

ROE

CYPH

-92.0%

ARTV

-6022.0%

FCF Yield %

CYPH

-11.1%

ARTV

-22.8%

52-Week Performance

CYPH

292.0%

ARTV

131.3%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

CYPH

Cypherpunk Technologies Inc

Market Cap

ARTV$337M

CYPH$313M

Enterprise Value

ARTV$36M

CYPH$305M

Price

ARTV$6.94

CYPH$2.94

P/E Ratio

ARTVN/A

CYPHN/A

P/S Ratio

ARTV0.00x

CYPH217.68x

EV/Sales

ARTV0.00x

CYPH0.00x

EV/EBITDA

ARTV0.00x

CYPH0.00x

P/B Ratio

ARTV0.96x

CYPH2.34x

P/FCF Ratio

ARTVN/A

CYPHN/A

EV/FCF

ARTV-0.46x

CYPH-8.83x

PEG Ratio

ARTVN/A

CYPHN/A

Forward P/E (NTM)

ARTVN/A

CYPH26.20x

Forward P/S (NTM)

ARTVN/A

CYPH6.06x

Revenue (TTM)

ARTV$0

CYPH$0

Revenue Growth (YoY)

ARTVN/A

CYPHN/A

Forward Rev Growth

ARTV404.4%

CYPH155.2%

Gross Margin (TTM)

ARTV0.0%

CYPH0.0%

Operating Margin (TTM)

ARTV0.0%

CYPH0.0%

EBITDA Margin (TTM)

ARTV0.0%

CYPH0.0%

Net Margin (TTM)

ARTV0.0%

CYPH0.0%

FCF Margin (TTM)

ARTVN/A

CYPHN/A

Net Income (TTM)

ARTV$-42M

CYPH$-877K

FCF (TTM)

ARTV$-77M

CYPH$-35M

EPS (TTM)

ARTV$0.00

CYPH-$0.00

ROE (TTM)

ARTV-6022.0%

CYPH-92.0%

ROA (TTM)

ARTV-5238.0%

CYPH-87.0%

ROIC (TTM)

ARTV-6019.0%

CYPH-92.0%

Cash

ARTV$301M

CYPH$8M

Debt

ARTV$0

CYPH$0

Net Cash/Debt

ARTV$301M

CYPH$8M

Current Ratio (TTM)

ARTV24.16x

CYPH79.19x

Quick Ratio (TTM)

ARTV23.97x

CYPH78.88x

Debt/Equity (TTM)

ARTV0.00x

CYPH0.00x

Debt/Assets (TTM)

ARTV0.0%

CYPH0.0%

Interest Coverage (TTM)

ARTVN/A

CYPHN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

CYPH0.00x

Beta

ARTV5.80

CYPH1.13

52W Performance

ARTV131.3%

CYPH292.0%

YTD Performance

ARTV64.1%

CYPH160.2%

% from 52W High

ARTV-52.2%

CYPH-29.8%

% from 52W Low

ARTV156.1%

CYPH648.1%

Asset Turnover (TTM)

ARTV0.00x

CYPH0.02x

FCF Yield (TTM)

ARTV-22.8%

CYPH-11.1%

Earnings Yield (TTM)

ARTV-12.5%

CYPH-0.3%

Dividend Yield (TTM)

ARTVN/A

CYPHN/A

Rule of 40

ARTV0.0

CYPH0.0

EV/GP/RG

ARTVN/A

CYPHN/A

Ticker research

View ARTV research View CYPH research

Metric	ARTV Artiva Biotherapeutics Inc	CYPH Cypherpunk Technologies Inc
Market & Valuation
Market Cap	$337M	$313M
Enterprise Value	$36M	$305M
Price	$6.94	$2.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	217.68x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	2.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-8.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	26.20x
Forward P/S (NTM)	N/A	6.06x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	155.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-42M	$-877K
FCF (TTM)	$-77M	$-35M
EPS (TTM)	$0.00	-$0.00
ROE (TTM)	-6022.0%	-92.0%
ROA (TTM)	-5238.0%	-87.0%
ROIC (TTM)	-6019.0%	-92.0%
Financial Health
Cash	$301M	$8M
Debt	$0	$0
Net Cash/Debt	$301M	$8M
Current Ratio (TTM)	24.16x	79.19x
Quick Ratio (TTM)	23.97x	78.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.13
52W Performance	131.3%	292.0%
YTD Performance	64.1%	160.2%
% from 52W High	-52.2%	-29.8%
% from 52W Low	156.1%	648.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-22.8%	-11.1%
Earnings Yield (TTM)	-12.5%	-0.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View CYPH research